Tim Tebow suffers apparent leg injury during Arizona Fall League game

Christian Petersen/Getty Images
17 Comments

Update (8:43 PM EDT): The Mets say Tebow is day-to-day with minor irritation in his right knee, per ESPN’s Adam Rubin.

*

Mets minor league outfielder Tim Tebow, playing for the Scottsdale Scorpions in the Arizona Fall league, suffered an apparent leg injury during a game on Monday afternoon, minor league photographer Bill Mitchell reports. With a runner on first base and one out in the bottom of the fourth inning, Tebow hit into a fielder’s choice 6-4 ground out. During the next at-bat, he attempted to steal second base, but was thrown out to end the inning and appeared to suffer a leg injury in the process.

Tebow did not come back out to play defense the next inning as Aaron Brown replaced him in left field. Tebow ended the afternoon 1-for-2 with a single. The severity of the injury is not yet known, but we should have a better idea in a few hours.

After Monday’s effort, Tebow is currently batting .147 (5-for-34) with a double and two runs scored. Only two players — Danny Mars and Drew Jackson — have a lower OPS than Tebow’s .371 in the AFL.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.